The Ensign Group, Inc. $ENSG Stake Decreased by Rhumbline Advisers

Rhumbline Advisers trimmed its holdings in The Ensign Group, Inc. (NASDAQ:ENSG) by 11.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 188,232 shares of the company’s stock after selling 24,375 shares during the quarter. Rhumbline Advisers’ holdings in The Ensign Group were worth $32,521,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in The Ensign Group by 33.4% during the second quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 45,962 shares of the company’s stock worth $7,090,000 after acquiring an additional 11,496 shares during the period. ABN AMRO Bank N.V. bought a new position in shares of The Ensign Group during the 2nd quarter valued at about $970,000. SG Americas Securities LLC boosted its position in shares of The Ensign Group by 378.6% during the 3rd quarter. SG Americas Securities LLC now owns 22,346 shares of the company’s stock valued at $3,861,000 after purchasing an additional 17,677 shares in the last quarter. Baillie Gifford & Co. raised its holdings in shares of The Ensign Group by 96.2% in the 3rd quarter. Baillie Gifford & Co. now owns 2,818,609 shares of the company’s stock worth $486,971,000 after purchasing an additional 1,382,035 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new stake in shares of The Ensign Group in the 3rd quarter worth approximately $6,157,000. Institutional investors own 96.12% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on ENSG. Stephens lifted their price target on shares of The Ensign Group from $185.00 to $200.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of The Ensign Group in a report on Thursday, January 22nd. Royal Bank Of Canada reissued an “outperform” rating and issued a $222.00 price target (up previously from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Finally, UBS Group set a $230.00 price objective on The Ensign Group and gave the stock a “buy” rating in a report on Friday, February 6th. Five research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $204.60.

Insider Transactions at The Ensign Group

In related news, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction on Monday, December 1st. The stock was sold at an average price of $184.27, for a total transaction of $128,989.00. Following the completion of the sale, the director owned 24,352 shares of the company’s stock, valued at approximately $4,487,343.04. This trade represents a 2.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Daren Shaw sold 1,000 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $178.57, for a total value of $178,570.00. Following the completion of the transaction, the director owned 24,126 shares in the company, valued at $4,308,179.82. This trade represents a 3.98% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 29,032 shares of company stock worth $5,373,698. 3.90% of the stock is owned by company insiders.

The Ensign Group Stock Performance

Shares of The Ensign Group stock opened at $213.34 on Monday. The Ensign Group, Inc. has a 12 month low of $118.73 and a 12 month high of $216.92. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.06. The stock has a market cap of $12.36 billion, a PE ratio of 36.53, a price-to-earnings-growth ratio of 2.23 and a beta of 0.88. The business has a fifty day simple moving average of $180.23 and a 200-day simple moving average of $176.35.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.07. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. During the same period in the prior year, the business earned $1.49 EPS. The business’s revenue for the quarter was up 20.2% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. On average, sell-side analysts anticipate that The Ensign Group, Inc. will post 5.59 EPS for the current fiscal year.

The Ensign Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Saturday, January 31st. Investors of record on Wednesday, December 31st were given a dividend of $0.065 per share. The ex-dividend date of this dividend was Wednesday, December 31st. This is a boost from The Ensign Group’s previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The Ensign Group’s payout ratio is presently 4.45%.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.